Stephens Consulting, LLC Mirum Pharmaceuticals, Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 10 shares of MIRM stock, worth $391. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$391% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
212Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$257 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$179 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$127 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$109 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$102 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.44B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...